Roxatidine Acetate Hydrochloride

醋酸罗沙替丁盐酸盐

Report date: 2023/03/22 16:58:04
NME

Base Information

Drug NameRoxatidine Acetate Hydrochloride
Drug Alias NameRoxatidina盐酸醋酸罗沙替丁Roxatidine盐酸乙酰罗沙替丁盐酸乙酸罗沙替丁 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsUlcerHyperemesis GravidarumStomach Ulcer +[9] 
Global Approved IndicationsUlcerHyperemesis GravidarumStomach Ulcer +[9] 
Approved Indications in ChinaHyperemesis GravidarumPeptic UlcerGastroesophageal Reflux +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1986/07/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChongqing Shenghuaxi Pharmaceutical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdChongqing Shenghuaxi Pharmaceutical Ltd
Inactive CompaniesN/A
Active IndicationsUlcerHyperemesis GravidarumStomach Ulcer +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BA06
Related LinksWikipediaDrugBankKEGG